BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a spectrum of liver conditions related to fat infiltration. The role of liver triacylglycerol accumulation in NAFLD is not fully understood. METHODS: Twenty-four patients, 12 in the first and 12 in the second stage of NAFLD, were prospectively enrolled in this study. Biochemical parameters and eicosanoids (HETE and HODE) were compared between the first and the second stage of hepatic steatosis and the effect of a 6-month dietary intervention on these parameters was evaluated. Eicosanoid profiles were extracted from 0.5 ml of plasma using solid-phase extraction RP-18 SPE columns. The HPLC separations were performed on a 1260 liquid chromatograph. RESULTS: Patients with stage I NAFLD had a significantly higher level of HDL cholesterol and a lower level of 5-HETE. Patients with grade II steatosis had higher concentrations of 9-HODE. Following the six-month dietary intervention, hepatic steatosis resolved completely in all patients. This resulted in a significant decrease in the concentrations of all eicosanoids (LX4, 16-HETE, 13-HODE, 9-HODE, 15-HETE, 12-HETE, 5-oxoETE, 5-HETE) and key biochemical parameters (BMI, insulin, HOMA-IR, liver enzymes). CONCLUSION: A significant reduction in the analyzed eicosanoids and a parallel reduction in fatty liver confirmed the usefulness of HETE and HODE in the assessment of NAFLD.
BACKGROUND:Nonalcoholic fatty liver disease (NAFLD) is a spectrum of liver conditions related to fat infiltration. The role of liver triacylglycerol accumulation in NAFLD is not fully understood. METHODS: Twenty-four patients, 12 in the first and 12 in the second stage of NAFLD, were prospectively enrolled in this study. Biochemical parameters and eicosanoids (HETE and HODE) were compared between the first and the second stage of hepatic steatosis and the effect of a 6-month dietary intervention on these parameters was evaluated. Eicosanoid profiles were extracted from 0.5 ml of plasma using solid-phase extraction RP-18 SPE columns. The HPLC separations were performed on a 1260 liquid chromatograph. RESULTS:Patients with stage I NAFLD had a significantly higher level of HDL cholesterol and a lower level of 5-HETE. Patients with grade II steatosis had higher concentrations of 9-HODE. Following the six-month dietary intervention, hepatic steatosis resolved completely in all patients. This resulted in a significant decrease in the concentrations of all eicosanoids (LX4, 16-HETE, 13-HODE, 9-HODE, 15-HETE, 12-HETE, 5-oxoETE, 5-HETE) and key biochemical parameters (BMI, insulin, HOMA-IR, liver enzymes). CONCLUSION: A significant reduction in the analyzed eicosanoids and a parallel reduction in fatty liver confirmed the usefulness of HETE and HODE in the assessment of NAFLD.
Authors: Yuriko Adkins; Benjamin J Belda; Theresa L Pedersen; Dawn M Fedor; Bruce E Mackey; John W Newman; Darshan S Kelley Journal: Lipids Date: 2017-04-13 Impact factor: 1.880
Authors: Fen Yin; Rajat Gupta; Laurent Vergnes; Will S Driscoll; Jerry Ricks; Gajalakshmi Ramanathan; James A Stewart; Diana M Shih; Kym F Faull; Simon W Beaven; Aldons J Lusis; Karen Reue; Michael E Rosenfeld; Jesús A Araujo Journal: Arterioscler Thromb Vasc Biol Date: 2019-07-25 Impact factor: 8.311
Authors: John J Guardiola; Juliane I Beier; K Cameron Falkner; Benjamin Wheeler; Craig James McClain; Matt Cave Journal: Toxicol Appl Pharmacol Date: 2016-10-17 Impact factor: 4.219
Authors: Manuel Garcia-Jaramillo; Melinda H Spooner; Christiane V Löhr; Carmen P Wong; Weijian Zhang; Donald B Jump Journal: PLoS One Date: 2019-04-03 Impact factor: 3.240
Authors: Katarzyna Grzesiak; Aleksandra Rył; Ewa Stachowska; Marcin Słojewski; Iwona Rotter; Weronika Ratajczak; Olimpia Sipak; Małgorzata Piasecka; Barbara Dołęgowska; Maria Laszczyńska Journal: Int J Environ Res Public Health Date: 2019-03-20 Impact factor: 3.390
Authors: Anastasia Asimakopoulou; Kathrin M Engel; Nikolaus Gassler; Thilo Bracht; Barbara Sitek; Eva M Buhl; Stavroula Kalampoka; Manuela Pinoé-Schmidt; Josef van Helden; Jürgen Schiller; Ralf Weiskirchen Journal: Cells Date: 2020-05-28 Impact factor: 6.600